SCHEMBL18152041

SCHEMBL18152041

COc1ccc(CN(O)C(=O)c2ccc3c(c2)OC2(CCNCC2)CC3)cc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
OPRD1 P41143 4/20 0.38
OPRM1 P35372 1/20 0.38
HTR2A P28223 3/20 0.38
DRD2 P14416 1/20 0.38
HTR2C P28335 1/20 0.38
ACHE P22303 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
PPARA Q07869 1/20 0.35
CYP2D6 P10635 3/20 0.35
KCNH2 Q12809 3/20 0.35
RAB9A P51151 3/20 0.34
MAPT P10636 2/20 0.34
NPC1 O15118 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18152038 0.87 OPRD1 (0.41) OPRD1OPRM1HTR2ADRD2HTR2C
SCHEMBL18153791 0.79 HTR2A (0.44) KMT2AOPRD1OPRM1HTR2ADRD2
SCHEMBL18152170 0.78 MEN1 (0.39) MEN1KMT2AOPRD1OPRM1HTR2A
SCHEMBL18153773 0.78 MEN1 (0.39) MEN1KMT2AOPRD1OPRM1HTR2A
SCHEMBL28524517 0.76 HTR2C (0.52) OPRD1OPRM1HTR2ADRD2HTR2C
SCHEMBL18148508 0.76 OPRD1 (0.45) MEN1KMT2AOPRD1SMN1; SMN2ALDH1A1
SCHEMBL18159334 0.74 MAPT (0.41) MEN1KMT2AOPRD1OPRM1ALDH1A1
SCHEMBL18153894 0.74 MEN1 (0.38) MEN1KMT2AOPRD1OPRM1HTR2A
SCHEMBL18152127 0.74 MEN1 (0.38) MEN1KMT2AOPRD1OPRM1HTR2A
SCHEMBL18153708 0.74 MEN1 (0.38) MEN1KMT2AOPRD1OPRM1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016168598-A1 3-SPIROCYCLIC-6-HYDROXAMIC ACID TETRALINS AS HDAC INHIBITORS FORMA THERAPEUTICS, INC. (US) 2016-10-20 WO claimed
WO-2016168598-A1 3-SPIROCYCLIC-6-HYDROXAMIC ACID TETRALINS AS HDAC INHIBITORS FORMA THERAPEUTICS, INC. (US) 2016-10-20 WO disclosed